News
$ATNM ATNM ATNM - Actinium Pharmaceuticals Presents EANM 2026 Results Reinforcing ATNM-400's Pan-Tumor Potential Across Lung, Colorectal and Ovarian C
Oct 20, 2026 · ThinkSabio Blog
$ATNM ATNM ATNM - Actinium Pharmaceuticals Presents EANM 2026 Results Reinforcing ATNM-400's Pan-Tumor Potential Across Lung, Colorectal and Ovarian Cancer Models
20-OCT-2026 07:31 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
